A SILICON-BASED COLOR LIQUID CRYSTAL DISPLAY MICRODEVICE

Details for Australian Patent Application No. 2003234977 (hide)

Owner FAN, Bin SHAO, Jianxin

Inventors SHAO, Jianxin; FAN, Bin

Pub. Number AU-A-2003234977

PCT Number PCT/CN03/00348

PCT Pub. Number WO2003/096107

Priority 02217356.0 14.05.02 CN

Filing date 14 May 2003

Wipo publication date 11 November 2003

International Classifications

G02F 001/13 Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating - based on liquid crystals, e.g. single liquid crystal display cells

Event Publications

28 August 2003 Complete Application Filed

  Priority application(s): 02217356.0 14.05.02 CN

15 January 2004 Application Open to Public Inspection

  Published as AU-A-2003234977

3 February 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

10 December 2009 Corrigenda

  Applications OPI - Name Index Under the name FAN, Bin, SHAO, Jianxin, Application No. 2003234977, under INID (43) correct the publication date to read 24.11.2003

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003234978-METHOD FOR FORWARDING MES- SAGE BETWEEN THE DIFFERENT MULTIMEDIA MESSAGE CENTERS

2003234976-THE USE OF THE HUMAN URINARY KININOGENASE IN THE MANUFACTURE OF A MEDICINE FOR TREATING AND PREVENTING CEREBRAL EMBOLISM